Skip to Main Content

Paper Details

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
PLoS One
34
2015
AURKA, BRCA1, BRCA1 mutation, BRCA1/2, BRCA2, BRCA2 mutation, CSTF1, CSTF1 rs6064391, HMMR, HMMR rs299290, RHAMM, SNPs, TPX2, TUBG1, TUBG1 rs11649877, breast cancer, mammary epithelial, patients, rs11649877, rs2426618, rs299290, rs6064391, single nucleotide polymorphisms, sporadic, sporadic breast tumors
Author NameAffiliation
Javier Ben??tezSpanish National Cancer Centre (CNIO)
Ana OsorioSpanish National Cancer Centre (CNIO)
Teresa Ram??n y CajalHospital de la Santa Creu i Sant Pau
Beth Y KarlanWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Jenny LesterWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Robert L NussbaumUniversity of California San Francisco
Irene L AndrulisSamuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto
Irene L AndrulisSamuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto
Susan M DomchekAbramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine
Katherine L NathansonAbramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine
Timothy R RebbeckAbramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine
Jan LubinskiPomeranian Medical University
Jan LubinskiPomeranian Medical University
Alison M DunningUniversity of Cambridge
Caroline SeynaeveFamily Cancer Clinic, Erasmus University Medical Center
Gustavo C RodriguezNorthShore University HealthSystem, University of Chicago
Doris SteinemannInstitute of Cell and Molecular Pathology, Hannover Medical School
Siranoush ManoukianIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT)
Paolo RadiceIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT)
Esther M JohnCancer Prevention Institute of California
Mary Beth TerryColumbia University
Wendy K ChungColumbia University Medical Center
Wendy K ChungColumbia University Medical Center
David E GoldgarUniversity of Utah School of Medicine
David E GoldgarUniversity of Utah School of Medicine
Judy E GarberCenter for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School
Amanda B SpurdleQueensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute
Amanda B SpurdleQueensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute
Sue HealeyQueensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute
Sue HealeyQueensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute
Chiara GorriniThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network
Holger HeynL'Hospitalet del Llobregat
Noralane M LindorCenter for Individualized Medicine, Mayo Clinic
Noralane M LindorCenter for Individualized Medicine, Mayo Clinic
Douglas F EastonUniversity of Cambridge
Georgia Chenevix-TrenchQueensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute
Georgia Chenevix-TrenchQueensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
  • 1 - 39

Datasets